NCT01839877View on ClinicalTrials.gov

Intra-arterial Hepatic Beads Loaded With Irinotecan With Concomitant Chemotherapy With FOLFOX in Patients With Colorectal Cancer With Unresectable Liver Metastases: a Phase II Multicenter Study

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

December 31, 2017

Study Completion Date

January 31, 2019

Conditions

Colorectal Cancer With Non Resectable Hepatic Metastasis

Interventions

DRUG

HIA DEBIRI + systemic FOLFOX

Trial Locations (9)

13273

Institut Paoli Calmette, Marseille

13385

CHU de la TIMONE, Marseille

31059

Hôpital Rangueil, Toulouse

33075

Hopital Saint André, Bordeaux

69008

Hôpital Prive Jean Mermoz, Lyon

69373

Centre Léon Berard, Lyon

75015

Hôpital Europeen G Pompidou, Paris

76031

CHU Charles Nicolle, Rouen

Unknown

CHU - Hôpital François Mitterand, Dijon

All Listed Sponsors

collaborator

Biocompatibles UK Ltd

INDUSTRY

lead

Federation Francophone de Cancerologie Digestive

OTHER

NCT01839877 - Intra-arterial Hepatic Beads Loaded With Irinotecan With Concomitant Chemotherapy With FOLFOX in Patients With Colorectal Cancer With Unresectable Liver Metastases: a Phase II Multicenter Study | Biotech Hunter | Biotech Hunter